Researchers Make Insulin-Producing Cells From Adult Skin Cells

Related Encyclopedia • Addison's Disease • Carcinoid Syndrome • Congenital Adrenal Hyperplasia • Cushing's Syndrome More... Related Healthscout Videos Removing Tumors Through the Nose Kids Diagnosing Themselves Reversing Nerve Damage Monitoring Diabetes More... Related Animations • Diabetes More... Related Drug Information • Actonel • Actos • Amaryl • Avandamet More... Related News Articles • Adding Fish Oil to Low-Fat/High-Carb Diet May Improve Cholesterol • Green, Leafy Vegetables Linked to Lower Type 2 Diabetes Risk • Long-Term Type 1 Diabetes 'Survivors' Give Clues to the Disease • Weight-Loss Surgery May Cut Type 2 Diabetes Medication Use More...

Page:  << Prev | 1 | 2 | 3 | Next >>

In the current study, researchers from the Howard Hughes Medical Institute at the Harvard Stem Cell Institute and the Naomi Berrie Diabetes Center at Columbia University, obtained skin samples from two white males who had type 1 diabetes. One was diagnosed at 3 years of age, while the other was first diagnosed when he was 21.

Normal skin cells are already specialized cells. Their job is to protect the body with a covering of skin, explained Firpo. To transform these cells into embryonic-like stem cells, essentially getting them back to the beginning when they weren't already specialized, researcher Doug Melton and his colleagues used three inserted genes to reprogram the cells, creating what's known as an induced pluripotent stem cell (iPS). In this case, the cells were then turned into insulin-producing cells.

Along with helping to provide a model of type 1 diabetes, this technology might also one day be used to create islet cells for transplant from a person's own skin cells. That way, there would be no need for immunosuppressive medications.

Text Continues Below

---

However, because the current technique uses genetic manipulation to change the cell, Firpo said long-term safety issues would have to be addressed. Mouse cells that have been similarly manipulated have developed benign tumors, she said. So, using such cells for transplant is definitely not "a near-term thing," she stressed.

The practical implications from this study "are primarily research-related," said Julia Greenstein, director of beta cell replacement for the Juvenile Diabetes Research Foundation (JDRF) in New York City.

She said that this study helps further at least two areas of research that JDRF is focusing on: developing a self-source for islet-cell transplants and blocking the immune response. Another area of research that JDRF is actively pursuing is the possible encapsulation of islet cells before transplantation so that they could hide from the immune system.

Page:  << Prev | 1 | 2 | 3 | Next >>